COMMUNIQUÉ DE PRESSE publié le 05/09/2025 à 15:00, il y a 4 mois 29 jours Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board Onco-Innovations appoints Dr. John Mackey, expert in oncology and clinical trials, to Scientific & Clinical Advisory Board, enhancing translational research capabilities for PNKP inhibitor program Clinical Trials Oncology Onco-Innovations PNKP Inhibitor Dr. John Mackey
BRÈVE publiée le 15/08/2025 à 15:20, il y a 5 mois 20 jours Onco-Innovations Achieves High Warrant Exercise Rate Warrants Non-dilutive Financing Cancer Research Shareholder Confidence Capital Strategy
BRÈVE publiée le 15/08/2025 à 15:20, il y a 5 mois 20 jours Onco-Innovations atteint un taux d'exercice de mandat élevé Financement Non Dilutif Confiance Des Actionnaires Mandats Stratégie De Capital Recherche Sur Le Cancer
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 15:15, il y a 5 mois 20 jours Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRÈVE publiée le 13/08/2025 à 23:05, il y a 5 mois 21 jours Onco-Innovations clôture un placement privé de 400 000 $ Placement Privé Réglementation Des Valeurs Mobilières Actions Et Bons De Souscription Onco-Innovations Financement Et Développement
BRÈVE publiée le 13/08/2025 à 23:05, il y a 5 mois 21 jours Onco-Innovations Closes $400,000 Private Placement Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
COMMUNIQUÉ DE PRESSE publié le 13/08/2025 à 23:00, il y a 5 mois 21 jours Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
BRÈVE publiée le 04/08/2025 à 22:10, il y a 5 mois 30 jours Onco-Innovations ouvre la voie aux essais cliniques sur l'homme grâce à un accord clinique avancé Essai Clinique Onco-Innovations Inhibiteur De PNKP Avance Clinique Préparations Réglementaires
BRÈVE publiée le 04/08/2025 à 22:10, il y a 5 mois 30 jours Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
COMMUNIQUÉ DE PRESSE publié le 04/08/2025 à 22:05, il y a 5 mois 30 jours Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement Onco-Innovations partners with Avance Clinical for regulatory and clinical documentation for their PNKP inhibitor therapy. Collaboration aims to advance cancer trials Clinical Trials Cancer Research Onco-Innovations Regulatory Support Avance Clinical
Publié le 04/02/2026 à 18:04, il y a 39 minutes Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 58 minutes Information concerning the total number of voting rights and shares 2026 01 31
Publié le 04/02/2026 à 17:45, il y a 58 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 04/02/2026 à 16:15, il y a 2 heures 28 minutes Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Publié le 04/02/2026 à 15:45, il y a 2 heures 58 minutes Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Publié le 04/02/2026 à 15:00, il y a 3 heures 43 minutes Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Publié le 04/02/2026 à 18:05, il y a 38 minutes INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
